Tower Research Capital LLC (TRC) - NEUROBO PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

NEUROBO PHARMACEUTICALS INC's ticker is and the CUSIP is 64132R206.

Links
Filings
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,878
+21.7%
12,348
+11.8%
0.00%–
Q2 2023$4,828
+120600.0%
11,047
+105.1%
0.00%–
Q1 2023$40.0%5,3850.0%0.00%–
Q4 2022$4
-99.8%
5,385
+2925.3%
0.00%–
Q3 2022$2,000–178–0.00%–
 Download
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 841,815$604,0020.53%
CVI Holdings, LLC 215,045$154,2950.02%
Engineers Gate Manager LP 19,693$14,1300.00%
Walleye Capital LLC 95,000$68,1630.00%
Kingsview Wealth Management, LLC 17,839$12,7990.00%
Virtu Financial LLC 13,953$100.00%
UBS Group AG 3,627$2,6110.00%
Squarepoint Ops LLC 24,146$17,3250.00%
TWO SIGMA INVESTMENTS, LP 65,035$46,6630.00%
BANK OF AMERICA CORP /DE/ 8$60.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders